4//SEC Filing
aTYR PHARMA INC 4
Accession 0001209191-17-009057
$ATYRCIK 0001339970operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:09 PM ET
Size
5.5 KB
Accession
0001209191-17-009057
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
King David John
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2017-02-07+65,000→ 65,000 totalExercise: $3.30Exp: 2027-03-07→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 7, 2017, such that this option will be fully exercisable on February 7, 2021. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001339970
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:09 PM ET
- Size
- 5.5 KB